share_log

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4:持股变动声明-高管 Dogan Meeshanthini
美股SEC公告 ·  2024/09/09 09:05

Moomoo AI 已提取核心信息

Cardio Diagnostics Holdings, Inc. CEO Dogan Meeshanthini completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 1,683,867 shares. The transaction, which took place in the open market, reflects the CEO's direct investment in the company's equity.
Cardio Diagnostics Holdings, Inc. CEO Dogan Meeshanthini completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 1,683,867 shares. The transaction, which took place in the open market, reflects the CEO's direct investment in the company's equity.
卡迪奥诊断控股公司首席执行官Dogan Meeshanthini于2024年9月6日完成了对公司股票的购买。该交易涉及以每股0.29美元的价格购买68,965股普通股。此次交易后,Meeshanthini在该公司的直接持股增至总共1,683,867股。这次交易发生在公开市场,反映了首席执行官对公司股权的直接投资。
卡迪奥诊断控股公司首席执行官Dogan Meeshanthini于2024年9月6日完成了对公司股票的购买。该交易涉及以每股0.29美元的价格购买68,965股普通股。此次交易后,Meeshanthini在该公司的直接持股增至总共1,683,867股。这次交易发生在公开市场,反映了首席执行官对公司股权的直接投资。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息